Clinical Trial Supply And Logistics Market Report 2026

Clinical Trial Supply And Logistics Market Overview

• Clinical Trial Supply And Logistics market size has reached to $5.1 billion in 2025 • Expected to grow to $7.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Clinical Trials Fuel Surge In Trial Supply And Logistics Market • Market Trend: Innovations In Temperature-Controlled Logistics For Clinical Trials Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the clinical trial supply and logistics market include: • Logistics And Distribution (Segmentation By By Service) → Expected gain of $0.77 Billion • Packaging Labelling And Blinding (Segmentation By By Service) → Expected gain of $0.53 Billion • Storage And Retention (Segmentation By By Service) → Expected gain of $0.49 Billion

What Is Covered Under Clinical Trial Supply And Logistics Market?

Clinical trial supply and logistics refers to the systematic procedure of ensuring the timely and cost-effective delivery of necessary supplies, equipment, and medications for the execution of a clinical study. This essential process ensures the safe and efficient conduct of the study while maintaining a focus on minimizing expenses. The main services offered in clinical trial supply and logistics are logistics and distribution, storage and retention, packaging labeling and blinding, manufacturing, comparator sourcing, and others. Logistics refers to developing a strategic strategy for moving commodities, whereas distribution carries out the conveyance of such goods using careful planning. The various clinical trial phases are phase I, phase II, phase III, and phase IV for different areas such as oncology, cardiovascular diseases, respiratory diseases, CNS (central nervous system) and mental disorders, and others that are used by several end-users, including pharmaceuticals, biologicals, and medical devices.

What Is The Clinical Trial Supply And Logistics Market Growth Forecast?

The clinical trial supply and logistics market size is expected to see strong growth in the next few years. It will grow to $7.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing adoption of decentralized clinical trials, rising demand for patient-centric supply models, expansion of biologics and cell therapy trials, growing investments in digital trial logistics platforms, increasing focus on real-time supply monitoring. Major trends in the forecast period include increasing adoption of integrated cold chain logistics, rising demand for end-to-end trial supply visibility, growing use of centralized inventory management models, expansion of direct-to-patient supply models, enhanced focus on risk mitigation and supply continuity.

What Is The Driver Of The Clinical Trial Supply And Logistics Market?

The increasing number of clinical trials is expected to propel the growth of the clinical trial supply and logistics market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Clinical trial supply and logistics are used to supply materials such as the collection and delivery of biological specimens, investigational drugs and kits, expertise and assistance with all permit applications and customs clearance, and others that are needed to conduct a clinical trial smoothly and ensure the successful execution of research studies. For instance, in July 2023, according to ClinicalTrials.gov, a US-based registry of clinical trials run by the United States National Library of Medicine at the National Institutes of Health (NIH), the number of registered clinical studies increased from 399,499 in 2022 to 437,533 until July of 2023 in all 50 states of the United States and across 221 countries. Moreover, it was reported that 141,513 studies (31% of the total) are registered in the U.S. only, while 244,707 studies (53% of the total) are registered in non-U.S. locations. Therefore, the increasing number of clinical trials is driving the growth of the clinical trial supply and logistics industry.

How Will The Drivers Impact Growth In The Global Clinical Trial Supply And Logistics Market?

• Increasing Number Of Global Clinical Trials (High) – During the forecast period, the increasing number of global clinical trials is expected to become a key growth driver for the clinical trial supply and logistics market by 2030. The steady rise in global clinical trial activity is a primary driver for the clinical trial supply and logistics market. Pharmaceutical and biotechnology companies are expanding trials across multiple geographies to accelerate drug development and regulatory approvals. This increases the need for efficient logistics services such as cross-border shipping, regulatory compliance, and timely delivery of investigational products. The complexity of managing multi-site trials further strengthens reliance on specialized supply chain providers. As trial volumes grow, demand for structured logistics solutions continues to expand. • Growing Complexity Of Clinical Trial Protocols (High) – During the forecast period, the growing complexity of clinical trial protocols is expected to emerge as a major factor driving the expansion of the clinical trial supply and logistics market by 2030. Clinical trials are becoming increasingly complex due to the adoption of biologics, cell and gene therapies, and personalized medicine approaches. These therapies require stringent handling conditions such as temperature control, specialized packaging, and precise inventory management. This complexity drives demand for advanced logistics solutions to ensure product integrity and regulatory compliance. Logistics providers play a critical role in minimizing risks such as spoilage or delays. As trial protocols evolve, the need for sophisticated supply chain services continues to increase. • Rising Demand For Real-Time Tracking And Supply Chain Visibility (Medium) – During the forecast period, the rising demand for real-time tracking and supply chain visibility is expected to act as a key growth catalyst for the clinical trial supply and logistics market by 2030. The need for transparency and control in clinical trial operations is driving the adoption of real-time tracking and monitoring solutions. Advanced track-and-trace systems enable stakeholders to monitor shipment conditions, ensure timely delivery, and maintain product quality. This reduces operational risks and enhances compliance with regulatory standards. Additionally, real-time visibility improves decision-making and trial efficiency. As digitalization increases, demand for integrated logistics technologies continues to drive market growth.

How Will The Restraints Impact Growth In The Global Clinical Trial Supply And Logistics Market?

• High Cost Of Specialized Logistics And Cold Chain Management (High) – During the forecast period, the clinical trial materials, especially biologics and temperature-sensitive drugs, require specialized storage, packaging, and transportation systems. These cold chain logistics solutions significantly increase operational costs for sponsors and service providers. High costs can limit adoption among smaller pharmaceutical and biotech companies. Additionally, maintaining strict temperature compliance across geographies adds financial and operational burden. This cost pressure restrains overall market expansion. • Stringent Regulatory And Import Export Compliance Requirements (High) – During the forecast period, the clinical trial logistics must comply with complex and varying regulations across different countries, including customs clearance and documentation standards. Delays due to regulatory approvals or non-compliance can disrupt trial timelines and increase costs. This complexity creates operational challenges for logistics providers managing global trials. Companies must invest heavily in compliance expertise and systems. Such regulatory barriers slow down market growth. • Risk Of Supply Chain Disruptions And Delays (Medium) – During the forecast period, the clinical trial supply chains are highly sensitive to disruptions such as transportation delays, geopolitical issues, or infrastructure limitations. Any delay in delivering investigational products can impact patient enrollment and trial continuity. Maintaining consistent supply across multiple sites is operationally challenging. These risks increase uncertainty and reduce efficiency in trial execution. As a result, supply chain vulnerabilities act as a key restraint for the market.

Key Players In The Global Clinical Trial Supply And Logistics Market

Major companies operating in the clinical trial supply and logistics market are United Parcel Service, DHL Group, FedEx Corporation, Thermo Fisher Scientific Inc., IQVIA, ICON plc, Eurofins Scientific, Catalent Inc., Intertek Group plc, Parexel International Corporation, UDG Healthcare PLC., Almac Group, World Courier, Piramal Pharma Solutions, Sharp Clinical Services Ltd., Clinigen Group, PCI Pharma Services, Movianto Group, Cold Chain Technologies, Biocair International Limited, QuickSTAT, Wasdell Group, Klifo A/S, TrakCel, Packaging Coordinators Inc., Biotec Services International Limited, Proventa International, Inceptua Group

Global Clinical Trial Supply And Logistics Market Trends and Insights

Major companies operating in the Clinical Trial Supply and Logistics Market are focused on technologies such as temperature-controlled healthcare shipments to enhance the integrity and reliability of their products during transport, ensuring compliance with regulatory standards and improving patient outcomes. Temperature-controlled healthcare shipments refer to the transport of medical products, pharmaceuticals, and biological materials that require specific temperature conditions to maintain their efficacy and safety. This process involves specialized packaging, monitoring systems, and logistics solutions to ensure products remain within the required temperature range throughout transit. For instance, in February 2024, FedEx Corporation, a US-based transport company launched FedEx Life Science Center. FedEx Customized Freight (FCF) for transporting critical pharmaceutical shipments. This includes features such as highest boarding priority, end-to-end custodial control, and dedicated delivery options tailored to maintain product integrity during transit. Additionally, customers can utilize FedEx Priority Alert Plus, which offers proactive monitoring of time-sensitive shipments with options for replenishment of dry ice or gel packs.

What Are Latest Mergers And Acquisitions In The Clinical Trial Supply And Logistics Market?

In November 2025, UPS Healthcare, a US-based logistics and supply chain solutions provider, acquired Andlauer Healthcare Group, for an undisclosed amount. With this acquisition, UPS Healthcare aims to expand its cold chain capabilities, strengthen temperature-sensitive healthcare logistics, enhance service coverage in North America, and improve the efficiency and reliability of pharmaceutical and biotech supply chains. Andlauer Healthcare Group is a Canada-based cold chain logistics company specializes in refrigerated and temperature-controlled transportation and storage solutions for healthcare products.

What Defines the Clinical Trial Supply And Logistics Market?

The clinical trial supply and logistics market includes revenues earned by entities by providing services such as clinical supply planning, import and export compliance, inventory management, packaging services, and real-time track and trace and delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Clinical Trial Supply And Logistics Market Report 2026?

The clinical trial supply and logistics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial supply and logistics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.